These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33606761)

  • 1. Amyotrophic Lateral Sclerosis (ALS) prediction model derived from plasma and CSF biomarkers.
    Khosla R; Rain M; Sharma S; Anand A
    PLoS One; 2021; 16(2):e0247025. PubMed ID: 33606761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis.
    Su XW; Simmons Z; Mitchell RM; Kong L; Stephens HE; Connor JR
    JAMA Neurol; 2013 Dec; 70(12):1505-11. PubMed ID: 24145899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying putative cerebrospinal fluid biomarkers of amyotrophic lateral sclerosis in a north Indian population.
    Khosla R; Rain M; Chawathey S; Modgil S; Tyagi R; Thakur K; Pannu V; Sharma SK; Anand A
    Muscle Nerve; 2020 Oct; 62(4):528-533. PubMed ID: 32696574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value.
    Noto Y; Shibuya K; Sato Y; Kanai K; Misawa S; Sawai S; Mori M; Uchiyama T; Isose S; Nasu S; Sekiguchi Y; Fujimaki Y; Kasai T; Tokuda T; Nakagawa M; Kuwabara S
    Amyotroph Lateral Scler; 2011 Mar; 12(2):140-3. PubMed ID: 21126161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis?
    Gille B; De Schaepdryver M; Dedeene L; Goossens J; Claeys KG; Van Den Bosch L; Tournoy J; Van Damme P; Poesen K
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1338-1346. PubMed ID: 31175169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UCHL1 from serum and CSF is a candidate biomarker for amyotrophic lateral sclerosis.
    Li R; Wang J; Xie W; Liu J; Wang C
    Ann Clin Transl Neurol; 2020 Aug; 7(8):1420-1428. PubMed ID: 32729234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of VEGF and VEGFR2 Receptor in Reversal of ALS-CSF Induced Degeneration of NSC-34 Motor Neuron Cell Line.
    Vijayalakshmi K; Ostwal P; Sumitha R; Shruthi S; Varghese AM; Mishra P; Manohari SG; Sagar BC; Sathyaprabha TN; Nalini A; Raju TR; Alladi PA
    Mol Neurobiol; 2015; 51(3):995-1007. PubMed ID: 24880751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.
    Rossi D; Volanti P; Brambilla L; Colletti T; Spataro R; La Bella V
    J Neurol; 2018 Mar; 265(3):510-521. PubMed ID: 29322259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A predictive model for amyotrophic lateral sclerosis (ALS) diagnosis.
    Gupta PK; Prabhakar S; Sharma S; Anand A
    J Neurol Sci; 2012 Jan; 312(1-2):68-72. PubMed ID: 21907354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylated neurofilament heavy chain levels in paired plasma and CSF of amyotrophic lateral sclerosis.
    Li S; Ren Y; Zhu W; Yang F; Zhang X; Huang X
    J Neurol Sci; 2016 Aug; 367():269-74. PubMed ID: 27423602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis.
    Steinacker P; Fang L; Kuhle J; Petzold A; Tumani H; Ludolph AC; Otto M; Brettschneider J
    PLoS One; 2011; 6(8):e23600. PubMed ID: 21858182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of serum and CSF neurofilament-light and neuroinflammatory biomarkers to evaluate ALS.
    Brodovitch A; Boucraut J; Delmont E; Parlanti A; Grapperon AM; Attarian S; Verschueren A
    Sci Rep; 2021 Jan; 11(1):703. PubMed ID: 33436881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Zheng Y; Gao L; Wang D; Zang D
    Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis.
    Scarafino A; D'Errico E; Introna A; Fraddosio A; Distaso E; Tempesta I; Morea A; Mastronardi A; Leante R; Ruggieri M; Mastrapasqua M; Simone IL
    J Neurol; 2018 Oct; 265(10):2353-2362. PubMed ID: 30116940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.
    Vu LT; Bowser R
    Neurotherapeutics; 2017 Jan; 14(1):119-134. PubMed ID: 27933485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
    Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
    Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal Fluid Neurofilaments May Discriminate Upper Motor Neuron Syndromes: A Pilot Study.
    Zucchi E; Bedin R; Fasano A; Fini N; Gessani A; Vinceti M; Mandrioli J
    Neurodegener Dis; 2018; 18(5-6):255-261. PubMed ID: 30428468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
    Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of CSF NfL and CSF TDP-43 improves diagnostic performance in ALS.
    Kasai T; Kojima Y; Ohmichi T; Tatebe H; Tsuji Y; Noto YI; Kitani-Morii F; Shinomoto M; Allsop D; Mizuno T; Tokuda T
    Ann Clin Transl Neurol; 2019 Dec; 6(12):2489-2502. PubMed ID: 31742901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.